Table 4: Summary of newer therapies for SLE.

Biological agentsRituximab
Ocrelizumab
Belimumab
Epratuzumab
Atacicept
Tocilizumab
Infliximab
Abatacept

Anticytokine therapiesAnti-TNFα
Anti-IFNy
Anti-interleukin 10
Anti-interleukin 6 receptor
Anti-interleukin 1 receptor
Anti- IFNα

Other techniquesImmunoadsorption
Anti-C5a
Peptide therapies
T cell vaccination
Costimulation inhibition with anti-CD154
B cell anergy with abetimus